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ABSTRACT
Histone H3K4me1/2 methyltransferases MLL3/MLL4
and H3K27 acetyltransferases CBP/p300 are major enhancer epigenomic writers. To understand
how these epigenomic writers orchestrate enhancer
landscapes in cell differentiation, we have profiled genomic binding of MLL4, CBP, lineagedetermining transcription factors (EBF2, C/EBP␤,
C/EBP␣, PPAR␥), coactivator MED1, RNA polymerase II, as well as epigenome (H3K4me1/2/3,
H3K9me2, H3K27me3, H3K36me3, H3K27ac), transcriptome and chromatin opening during adipogenesis of immortalized preadipocytes derived from
mouse brown adipose tissue (BAT). We show
that MLL4 and CBP drive the dynamic enhancer
epigenome, which correlates with the dynamic transcriptome. MLL3/MLL4 are required for CBP/p300
binding on enhancers activated during adipogenesis. Further, MLL4 and CBP identify super-enhancers
(SEs) of adipogenesis and that MLL3/MLL4 are required for SE formation. Finally, in brown adipocytes
differentiated in culture, MLL4 identifies primed SEs
of genes fully activated in BAT such as Ucp1. Comparison of MLL4-defined SEs in brown and white adipogenesis identifies brown-specific SE-associated
genes that could be involved in BAT functions.
These results establish MLL3/MLL4 and CBP/p300
as master enhancer epigenomic writers and suggest
that enhancer-priming by MLL3/MLL4 followed by
enhancer-activation by CBP/p300 sequentially shape
dynamic enhancer landscapes during cell differentiation. Our data also provide a rich resource for un-

derstanding epigenomic regulation of brown adipogenesis.
INTRODUCTION
Enhancers are transcription factor (TF) binding platforms that integrate and interpret genetic and environmental signaling cues during development. Enhancers play
a critical role in cell-type-specific gene expression during development (1). There are two major types of enhancers in mammalian cells, primed and active, which
are marked by distinct histone modification patterns.
Primed enhancers are marked by H3K4 mono- and dimethylations (H3K4me1/2) while active enhancers are
marked by H3K27 acetylation (H3K27ac) in addition to
H3K4me1/2 (2–4). The enhancer landscapes at different
stages of differentiation and development are often described in epigenomic profiling studies. However, to go beyond the level of description and to understand how the
enhancer landscape is created and reorganized, it is critical
to determine the genome-wide binding profiles of enhancer
epigenomic writers.
Our previous study identified MLL4 (KMT2D) and
the functionally redundant MLL3 (KMT2C) as major
H3K4me1/2 methyltransferases enriched on both primed
(previously described as silent) and active enhancers (5).
MLL3/MLL4 are essential for enhancer activation and
cell-type-specific gene expression during cell differentiation
(5,6). We also identified the functionally redundant CBP
and p300 as site-specific histone acetyltransferases responsible for H3K27ac in mammalian cells (7). CBP and p300 are
transcriptional coactivators enriched on active enhancers
(8). Thus, H3K4 methyltransferases MLL3/MLL4 and
H3K27 acetyltransferases CBP/p300 are major enhancer
epigenomic writers. However, the functional relationship
between MLL3/MLL4 and CBP/p300 in enhancer activation has remained unclear.
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Adipogenesis is under the control of a cascade of sequentially expressed TFs. PPAR␥ and C/EBP␣ are principal
adipogenic TFs while C/EBP␤ is an early TF facilitating
genomic binding of PPAR␥ , C/EBP␣ and other adipogenic
TFs (9–12). Epigenomic mechanisms involving chromatin
modifying enzymes also play critical roles in adipogenesis
(13–15). Enhancer epigenomic writers MLL3/MLL4 and
CBP/p300 are all essential for adipogenesis (5,16), although
the genome-wide binding profiles of CBP/p300 during adipogenesis have not been shown.
Brown adipose tissue (BAT) burns fat to generate heat
through mitochondrial uncoupling protein 1 (Ucp1) (17).
Understanding molecular mechanisms that promote the development of the thermogenic BAT and the expression of
Ucp1 and other BAT-enriched proteins may provide new
ways to treat obesity (18). Previous studies have identified the transcription cofactor Prdm16 as a potent promoter of brown adipogenesis (19). A recent study showed
that the adipogenic TF EBF2 determines and maintains
brown adipocyte identity. EBF2 promotes expression of
brown adipocyte genes by facilitating the genomic binding of PPAR␥ to its BAT-selective gene targets (20). However, epigenomic regulation of brown adipogenesis remains
poorly understood.
In this study, we investigate dynamics of transcriptome,
epigenome and epigenomic writers during adipogenesis
of immortalized preadipocytes derived from BAT. We focus on dynamic profiles of enhancer epigenomic writers
MLL4 and CBP, during adipogenesis, in addition to RNASeq of transcriptome, FAIRE-Seq of chromatin opening
and ChIP-Seq of histone modifications (H3K4me1/2/3,
H3K9me2, H3K27me3, H3K36me3 and H3K27ac), TFs
(EBF2, C/EBP␣, C/EBP␤, PPAR␥ and CTCF), transcription coactivator MED1 and RNA Polymerase II (Pol II).
This compendium not only enables systematic characterization of the dynamic coordination between transcriptome
and epigenome, but also provides a rich resource for understanding epigenomic regulation of brown adipogenesis.
We show that MLL3/MLL4 are required for enhancerbinding of CBP/p300, that MLL3/MLL4 are required for
the formation of super-enhancers (SEs) and that enhancerpriming by MLL3/MLL4 followed by enhancer-activation
by CBP/p300 sequentially shape the dynamic enhancer
landscapes during adipogenesis.
MATERIALS AND METHODS

(07-449, lot: DAM1387952) were from Millipore (Billerica,
MA, USA). Anti-H3K4me1 (ab8895, lot: GR612801), anti-H3K4me2 (ab7766, lot: GR102810-1), antiH3K9me2 (ab1220, lot: 957002), anti-H3K27ac (ab4729,
lot: GR81163-1), anti-H3K36me3 (ab9050, lot: 947436)
were from Abcam (Cambridge, MA, USA). Anti-UTX was
described previously (21). Anti-MLL4 and anti-SET1A
were described previously (22).

Immortalization of primary brown preadipocytes and adipogenesis assay
All mouse experiments were approved by the Animal Care
and Use Committee of NIDDK, NIH. Primary brown
preadipocytes were isolated from interscapular BAT of
newborn Pparγ f/f mice (Jackson no. 004584) and immortalized with SV40T-expressing retroviruses generated from
the pBabepuro-large T plasmid as described (23). For adipogenesis assay, cells were plated in growth medium (Dulbecco’s modified Eagle’s medium plus 10% fetal bovine
serum (FBS)) at a density of 1.8 × 106 cells per 15-cm dish
4 days before the induction of adipogenesis. At D0, confluent cells were induced with 0.02 M insulin, 1 nM T3, 0.5
mM 3-isobutyl-1-methyl-xanthine (IBMX), 2 g/ml dexamethasone and 0.125 mM indomethacin. At D2, D4 and
D6, the cells were replenished with medium containing 10%
FBS, 0.02 M insulin and 1 nM T3. Cells were collected for
ChIP-Seq, RNA-Seq and FAIRE-Seq at D-3, D0 (2 days
after confluence), D2 and D7.

ChIP-Seq, RNA-Seq and FAIRE-Seq sample preparation
ChIP-Seq and RNA-Seq were performed as described (5).
FAIRE-Seq samples were prepared by following a published protocol but with a few modifications (24). The procedures for crosslinking, sonication and cell lysis were the
same as in the ChIP-Seq protocol. The resulting sonicated
chromatin lysates were phase-separated by three rounds
of phenol/chloroform extraction. Nucleosome-free DNA
in the upper aqueous phase was precipitated with 0.3 M
sodium acetate (pH 5.2), 20 g glycogen and 2× volume
of ice-cold ethanol. DNA was further treated with 10 g of
RNase A and purified using the QIAquick PCR Purification Kit (QIAGEN).

Antibodies
The following antibodies were used in this study. AntiC/EBP␣ (sc-61X, lot: G1112), anti-C/EBP␤ (sc-150X, lot:
L2910), anti-PPAR␥ (sc-7196X, lot: H1512), anti-p300
(sc-585X, lot: E2209) were from Santa Cruz Biotechnology (Dallas, TX, USA). Anti-CBP (7389S, lot: 1) was
from Cell Signaling Technology (Danvers, MA, USA).
Anti-MED1/TRAP220 (A300-793A, lot: 2), anti-RbBP5
(AA300-109A), anti-Menin (A300-105A) were from
Bethyl Laboratories (Montgomery, TX, USA). AntiEBF2 (AF7006, lot: CEUA0113081) was from R&D
Systems (Minneapolis, MN, USA). Anti-CTCF (07-729,
lot: 2054523), Anti-Pol II (17-672, lot: 2015592), antiH3K4me3 (07-473, lot: 1974075) and Anti-H3K27me3

Western blot and immunoprecipitation experiments
Western blot of nuclear proteins using 50 g nuclear extracts, and immunoprecipitation from 0.5 mg nuclear extracts were done as described previously (22).

Illumina pipeline analysis for ChIP-Seq, RNA-Seq and
FAIRE-Seq data
Illumina pipeline analysis for ChIP-Seq, RNA-Seq and
FAIRE-Seq data and the visualization of the data on the
UCSC genome browser were performed as previously described (5).
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Identification of ChIP-enriched regions for ChIP-Seq data
and open chromatin region for FAIRE-Seq data
We determined ChIP-enriched regions using SICER (version 1.1) (25) as previously described (5). For ChIPSeq of histone modifications (H3K4me1/2/3, H3K27ac,
H3K36me3, H3K9me2 and H3K27me3), the window size
of 200 bp and the false discovery rate (FDR) of 10−3 were
used. For TFs (EBF2, C/EBP␤, C/EBP␣, PPAR␥ and
CTCF) and cofactors (CBP, MED1 and Pol II), the window
size of 50 bp and the FDR threshold of 10−10 were used.
The gap size for H3K36me3, H3K9me2 and H3K27me3
was chosen to be 2, 3 and 3 windows respectively, and the
gap size for other ChIP-Seq data was chosen to be 1 window. MLL4 binding sites were identified using ChIP-Seq
of MLL4 in MLL3/MLL4-deficient samples as the negative control (5). For other ChIP-Seq data, input libraries
were used as control in SICER. For FAIRE-Seq samples,
we ran SICER using a random background with window
size of 25 bp and gap size of 25 bp and an E-value of 1000.
Island-filtered reads were used for downstream analysis unless noted otherwise.
Gene annotation
We used the gene annotation from NCBI Reference Sequence Database (RefSeq) for mouse genome assembly
mm9.
Identification of promoters and enhancers
Promoters were defined as ±1 kb from the transcription
start sites (TSS). Promoters with H3K4me3 were regarded
as active promoters. Non-promoter regions with H3K4me1
but not H3K4me3 were identified as enhancers. Enhancers
with H3K27ac were defined as active enhancers. Enhancers
without H3K27ac were defined as primed enhancers.
Clustering of genes by gene expression
TopHat (version 2.0.10) (26) and Cufflinks packages (version 2.2.1) (27) were employed to calculate the fragments
per kilobase per million (FPKM) to measure the gene expression level. FPKMs were normalized with the median
of the geometric means of fragment counts across all the
libraries using Cuffnorm in Cufflinks package. Genes with
FPKM > 1 were regarded as expressed.
To investigate the dynamics of gene expressions, we collected genes expressed at any of the four time points during adipogenesis. For each such gene, the relative expression
level at each time point was calculated by normalizing its
FPKM value by the highest value of FPKM among the four
time points. Genes whose expression changes were >2-fold
between any two time points during adipogenesis were clustered using the K-Mean clustering into four groups (I-IV)
according to their dynamic relative expression levels. Genes
whose expression changes were <2-fold were regarded as
constitutively expressed genes and form the fifth group (V).
For Group I-IV, top 1000 genes with the largest expression
level changes were selected for gene ontology (GO) analysis
using DAVID (28) and for Group V, top 1000 genes with the
least expression variations were selected for GO analysis.

Temporal patterns of histone modifications
The temporal patterns of relative intensities of histone modifications were visualized using heat maps. The approach is
described as follows. For each histone modification, we define a set of regions as the common ground for comparison of signal levels across time points. The signal level on
each region is defined as the reads per million (RPM) on
that region normalized by the highest RPM value among
the four time points on that region. As such, the highest
signal level across the 4 time points for each region is always one. Each region was assigned to the gene whose TSS
is closest. The heat map intensity for each group of genes at
each time point is calculated by averaging the signal levels
of all the regions associated with genes in that group at that
time point. For H3K4me1/2 and H3K27ac, the set of regions is defined by union of enhancers identified at the four
time points; For H3K4me3, the regions are the promoters
([TSS−1K, TSS+1K]); For H3K36me3, The regions are the
gene bodies ([TSS, TES]); For H3K27me3, the set of regions
is defined by union of H3K27me3-enriched islands identified at the four time points.
MLL4 and CBP binding and association with enhancer
epigenome and transcriptome in adipogenesis
MLL4/CBP binding sites on enhancers between two successive time points (D-3 to D0, D0 to D2 and D2 to D7)
were classified into three types: decreased, unchanged and
increased. The classification is done as follows. The union
of MLL4/CBP binding sites on enhancers from two successive time points provides a set of common regions for
comparison across time points. SICER were used to determine whether the changes in intensities were significant
(with FDR < 1e-3) on these common regions. Regions
whose changes were not significant were designated as unchanged. The distributions of decreased, unchanged and increased MLL4/CBP binding were shown in the pie charts.
The fold changes of H3K4me1/H3K27ac intensities on the
MLL4/CBP sites as classified above were shown in the box
plots.
To characterize the temporal patterns of MLL4/CBP
binding on enhancers during adipogenesis, we obtained
the unions of all the MLL4/CBP binding sites on enhancers from four time points and calculated the intensity
of MLL4/CBP on the resulting regions at each time point.
We classified the temporal dynamics of MLL4/CBP binding on these regions into four patterns depending on which
time point the highest intensities of MLL4/CBP were at:
D-3, D0, D2 or D7. Next, the unions of MLL4/CBP binding sites were assigned to the nearest genes (TSSs). For
each gene group, we determined the enrichment (or depletion) of each of the four MLL4/CBP binding patterns, with
the significance determined using hypergeometric test. For
Group I-IV, the unions of MLL4/CBP binding sites associated with the most enriched temporal pattern were used for
the profiles of MLL4/CBP binding and their corresponding histone modifications from D-3 to D7 in the heat maps.
For Group V, for each gene the MLL4/CBP sites with the
same temporal pattern as the expression pattern were used
for the heat maps.
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MLL3/MLL4 facilitate CBP/p300 binding
To compare CBP/p300 signal on MLL4 binding sites on
active enhancers between Mll3/Mll4 double knockout (KO)
cells and control cells, average profiles and heat maps were
used to profile the CBP/p300 binding intensities within the
10 kb windows centered by MLL4 sites on active enhancers.
We also compared CBP/p300 signal changes at MLL4+ and
MLL4− CBP/p300 sites on active enhancers. Significance
was determined using Mann–Whitney test.
Analysis of super-enhancers
We used rank ordering of super-enhancers (ROSE) with default parameters (29) to identify SEs. To identify SEs using MLL4/CBP, we stitched together H3K4me1+ MLL4
or CBP binding sites in non-promoter regions and used
MLL4/CBP signal intensity for ranking. To identify SEs
using TFs + MED1, we stitched together binding sites of
master TFs (EBF2, C/EBP␤, C/EBP␣ and PPAR␥ ) and
used MED1 intensity for ranking. We associated SEs to the
proximal expressed genes within ±200 kb.
We compared MLL4/CBP signal levels between SE constituents (SECs) and typical enhancers (TEs). RPKM of
MLL4/CBP tags on SECs and TEs was used to measure
the signal levels. Significance was determined using Mann–
hitney test. To compare the MLL4-defined SEs at D0, D2
and D7, we used ROSE to determine MLL4-defined SEs for
each time point separately. Then we compared MLL4 signal
intensities on each set of SEs. Significance was determined
using Mann–Whitney test. For comparison of CBP, MED1
and H3K27ac signals on SEs between Mll3/Mll4 double
KO and control cells, RPM was calculated to measure the
signal levels. Significance was determined using Wilcoxon
test. For comparisons between MLL4-specific and common
SE-associated genes, genes associated with both MLL4specific and common SEs were excluded.
Genes associated with brown-specific SEs
SEs were determined by MLL4 ChIP-Seq for brown
adipocytes (D7) and 3T3L1 adipocytes (D7), respectively.
Brown-specific SEs were defined as brown SEs that did not
overlap 3T3L1 SEs. Genes selectively expressed in brown
adipocytes were defined as those (i) induced in brown adipogenesis, EdgeR was used to identify differentially expressed genes between D7 and D0 with FDR ≤ 0.05 and
fold change ≥ 2; and (ii) with expression higher in brown
adipocytes (D7) than in white adipocytes (D7) by at least
2-fold. Brown-specific SE-associated genes were defined as
genes selectively expressed in brown adipocytes with brownspecific SEs within 200 kbs.
Datasets
In the Pparγ f/f preadipocytes established in this study, we
generated FAIRE-Seq, RNA-Seq and ChIP-Seq of TFs
(EBF2, C/EBP␤, C/EBP␣, PPAR␥ and CTCF), cofactors (CBP, MED1 and Pol II) and histone modifications
(H3K4me1/2/3, H3K27ac, H3K36me3, H3K9me2 and
H3K27me3) at four time points (D-3, D0, D2, D7) of adipogenesis. In the Mll3−/− Mll4f/f preadipocytes described previously (5), we generated ChIP-Seq for CBP and p300 for

both Mll3/Mll4 double KO (Cre) and control (GFP) conditions at D2 of brown adipogenesis, as well as ChIP-Seq
of MLL4 at D-3. In addition, we generated ChIP-Seq of
MLL4 at D7 of adipogenesis in 3T3L1 cells. ChIP-Seq of
MLL4 at D0, D2 and D7 were from published data (GEO:
GSE50466) (5). We generated RNA-Seq data for BATderived from adult mouse. The ChIP-Seq of H3K4me1 and
H3K27ac for BAT, and the RNA-Seq for WAT were downloaded from the mouse ENCODE project (30). RNA-Seq
for 3T3L1 preadipocytes (D0 and D7) were downloaded
from (12). The data used in this study are summarized in
Supplementary Table S1.
Data reproducibility
For RNA-Seq data reproducibility, we generated biological replicates at all four time points (D-3, D0, D2 and D7)
of adipogenesis using two different brown preadipocyte cell
lines. We used Pearson correlations of expression values
between each pair of biological replicates to assess reproducibility. For reproducibility of ChIP-Seq of CBP, we generated biological replicates at D0, D2 and D7 using different
preadipocyte cell lines. To assess reproducibility, for each
pair of replicates, we identified ChIP-enriched regions using SICER for each replicate. Then ChIP-enriched regions
from the two replicates were merged and RPKM values for
each replicate were calculated on the merged regions. We
then calculated Pearson correlations of the RPKM values
of the pair of replicates. For reproducibility of ChIP-Seq of
TFs (C/EBP␤, C/EBP␣ and PPAR␥ ), CTCF, MED1, Pol
II and histone modifications (H3K4me1/2/3, H3K9me2,
H3K27me3, H3K27ac), we calculated Pearson correlations
between data generated in this study with those from different preadipocyte cell lines generated in our previously publications (5,31). As summarized in Supplementary Tables S2
and 3, the reproducibility of the RNA-Seq and ChIP-Seq
data generated in this study is demonstrated by high Pearson correlations values.
RESULTS
Dynamic enhancer epigenome correlates with dynamic transcriptome in adipogenesis
We investigated epigenomic regulation of adipogenesis using immortalized preadipocytes derived from BAT (Figure
1). We chose four time points that represent distinct stages
of adipogenesis: proliferating preadipocytes (day −3, D3), confluent preadipocytes before the induction of adipogenesis (day 0, D0), immature adipocytes undergoing adipogenesis (day 2, D2) and mature adipocytes after adipogenesis (day 7, D7) (Figure 1A and B). Oil Red O
staining confirmed robust adipogenesis of the immortalized preadipocytes (Figure 1C). Expression of adipogenesis markers Pparg, Cebpa, Fabp4 and the BAT marker
Ucp1 was markedly induced during adipogenesis (Figure 1D). Treating the differentiated adipocytes with ␤3 adrenergic receptor agonist CL-316,243 further induced
Ucp1 expression by ∼30-fold (Figure 1E). Using ChIP-Seq,
we identified genomic binding events of four adipogenic
TFs (EBF2, C/EBP␤, C/EBP␣, PPAR␥ ), CTCF, cofactors
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Figure 1. Characterization of immortalized brown preadipocytes derived from BAT. (A) Schematic of the adipogenesis assay. (B) Cell morphology under
microscope. (C) Oil Red O staining of differentiated cells 7 days after inducing adipogenesis. (D) qRT-PCR analysis of gene expression at indicated time
points of adipogenesis. (E) qRT-PCR analysis of Ucp1 and Pparg gene expression in fully differentiated adipocytes (D7, day 7) that were treated with 100
nM CL-316 243 for up to 6 h.

(MLL4, CBP, MED1), Pol II and seven histone modifications (H3K4me1/2/3, H3K27ac, H3K36me3, H3K9me2,
H3K27me3). Using RNA-Seq, we measured genome-wide
gene expression levels. Using FAIRE-Seq, we identified
open chromatin regions. These data are exemplified on gene
loci encoding Prdm16 and Ucp1 (Figure 2 and Supplementary Figure S1).
Adipogenic TFs (EBF2, C/EBP␤, C/EBP␣, PPAR␥ ),
cofactors (MLL4, CBP, MED1) and Pol II all show increased genomic binding on Prdm16 and Ucp1 loci after adipogenesis (D7), which are consistent with increased
levels of active histone modifications (H3K4me1/2/3,
H3K27ac, H3K36me3) from D0 to D7 (Figure 2 and Supplementary Figure S1). On the other hand, repressive histone modifications exhibit more divergent behaviors. G9amediated H3K9me2 decreases markedly during adipogenesis on the Ucp1 locus but is absent both before and after adipogenesis on the Prdm16 locus. Ezh2-mediated H3K27me3
decreases on the Ucp1 locus. The dynamic changes of the
epigenome are also accompanied by increased chromatin
opening and gene expression levels during adipogenesis
(Figure 2 and Supplementary Figure S1).

To investigate the relationship between epigenome and
transcriptome during adipogenesis, we began by characterizing the dynamic transcriptome. By K-means clustering, we classified all active genes into five groups according to their relative expression levels. Each group represents a specific temporal profile of expression: increased
throughout adipogenesis (group I), transiently increased
at D2 (II), transiently increased at D0 (III), decreased
throughout adipogenesis (IV) and constitutively expressed
(V) (Figure 3A and B). These five groups are associated
with functionally distinct GO terms (Figure 3C). Group I
genes, such as Prdm16, are induced throughout adipogenesis and are strongly associated with brown fat cell differentiation. Suppressors of adipogenesis, such as Wnt5a,
are often found in Group IV genes, whose expression levels decrease throughout adipogenesis. Representative genes
for each group are shown in Figure 3D. Using ChIP-Seq
data for histone modifications, we scored each gene for
H3K4me1/2 and H3K27ac levels on enhancers, H3K4me3
levels on promoters, H3K36me3 levels on gene bodies and
overall H3K27me3 levels at each time point. By comparing
temporal patterns of histone modifications and transcriptome for each gene group (Figure 3E), we observed that the

Nucleic Acids Research, 2017, Vol. 45, No. 11 6393

D2 or D7 (Supplementary Figure S2B). We found that the
most enriched MLL4/CBP binding patterns are congruent
with their corresponding gene expression patterns shown in
Figure 3B while the most depleted patterns anti-correlate.
As shown in heat maps, the most enriched MLL4/CBP
binding patterns correlate well with H3K4me1/H3K27ac
levels on enhancers (Figure 4D and E). The correlation between MLL4/CBP binding and H3K4me1/H3K27ac levels is also shown on two representative gene loci, Cebpa
of group I and Wnt10b of group IV (Supplementary Figure S3). Together with our previous observations that
MLL3/MLL4 are required for H3K4me1/2 and H3K27ac
on active enhancers during adipogenesis (5), these results
suggest that MLL3/MLL4 and CBP/p300 drive the dynamic enhancer epigenome during adipogenesis.
MLL3/MLL4 are required for CBP/p300 binding on enhancers activated in adipogenesis

Figure 2. Genome browser view of the Prdm16 locus before and after brown adipogenesis. ChIP-Seq, FAIRE-Seq and RNA-Seq data at
the Prdm16 locus before (D0) and after (D7) adipogenesis of brown
preadipocytes are shown. D0, day 0; D7, day 7.

dynamic enhancer epigenome marked by H3K4me1/2 and
H3K27ac correlates well with the dynamic transcriptome
during adipogenesis.
MLL4 and CBP drive the dynamic enhancer epigenome in
adipogenesis
To understand the mechanisms that regulate the dynamic
enhancer epigenome in adipogenesis, we characterized the
dynamics of genome-wide binding of the H3K4me1/2
methyltransferase MLL4 and the H3K27 acetyltransferase
CBP. Majority of MLL4 binding regions are located on
primed or active enhancers at all four time points, whereas
CBP binds to both active enhancers and active promoters (Figure 4A). MLL4 and CBP binding on enhancers are
highly dynamic, with over 67% of MLL4 and over 50% of
CBP sites showing significantly altered binding intensities
between any two adjacent time points during adipogenesis.
The most dramatic changes occur from D0 to D2, with only
7.4% of MLL4 and 20.4% of CBP binding on enhancers
remaining unchanged or showing mild changes (Supplementary Figure S2A). As expected, in general, increases in
MLL4 and CBP binding on enhancers correlate with increased H3K4me1 and H3K27ac levels, respectively. Interestingly, whereas the enhancers with decreased CBP binding
show a marked decrease in H3K27ac levels, the enhancers
with decreased MLL4 binding only show a mild decrease in
H3K4me1 levels (Figure 4B and C).
Next, we compared the temporal patterns of MLL4/CBP
binding with those of H3K4me1/H3K27ac on enhancers.
For each of the five gene groups, we classified enhancer
binding patterns of MLL4/CBP into four types according
to the time point of the highest binding intensities: D-3, D0,

Next, we investigated the relationship between
MLL3/MLL4 and CBP/p300 binding on enhancers.
H3K4me1/2 precedes H3K27ac on active enhancers during cell differentiation and animal development (3,5,32,33).
During cell differentiation, MLL3/MLL4 are required
for not only H3K4me1/2 but also H3K27ac on active enhancers (5). These observations suggest that MLL3/MLL4
could be required for binding and/or enzymatic activities
of CBP/p300 on enhancers activated during adipogenesis.
Indeed, deletion of Mll4 from Mll3 KO (Mll3−/− Mll4f/f )
preadipocytes largely prevented CBP/p300 binding on
MLL4+ active enhancers at D2 of adipogenesis (Figure 5A and B). Further, more severe impairments of
CBP/p300 binding were observed at MLL4+ than at
MLL4− CBP/p300 binding sites on active enhancers
(Figure 5C). Notably, Double KO of Mll3/Mll4 did not
change CBP/p300 protein levels in cells (Figure 5D). On
the Pparg locus, we also observed markedly decreased
CBP/p300 binding on MLL4+ active enhancers at D2 of
adipogenesis in the absence of MLL3/MLL4 (Figure 5E).
Immunoprecipitation using anti-MLL4, anti-CBP or antip300 antibody followed by western blot analysis failed to
detect a physical interaction between MLL4 and CBP/p300
at D2 of adipogenesis (Figure 5F). Together, these data
indicate that enhancer-priming by MLL3/MLL4 facilitates
CBP/p300 binding on, and activation of, enhancers during
adipogenesis.
MLL4 identifies and is required for super-enhancer formation
in adipogenesis
Next, we asked whether MLL4 and CBP could identify
SEs, which are clusters of active enhancers and are associated with cell identity genes (29). Canonically, SEs are
identified by large-scale clustering of master TF binding
sites and ranked by MED1 signal strength (29). We used
MLL4/CBP binding sites and their corresponding binding
intensities to identify and rank SEs. As a comparison, we
also identified SEs using TFs + MED1 (i.e. using EBF2,
C/EBP␤, C/EBP␣ and PPAR␥ binding sites to cluster and
MED1 levels to rank). We identified 438, 282 and 580 SEs
in D7 adipocytes using MLL4, CBP and TFs + MED1, respectively (Figure 6A and B). All three methods identified
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Figure 3. Dynamic enhancer epigenome correlates with the dynamic transcriptome during adipogenesis. (A–D) Characterization of the dynamic transcriptome. Genes are clustered according to their dynamic expression pattern during adipogenesis. (A) Heat map of clustered gene expression during
adipogenesis. The number of genes in each group is indicated. (B) Temporal profile of average relative expression levels for each group of genes. (C) Gene
ontology (GO) analysis of each group of genes. (D) Expression levels of a representative gene for each gene group during adipogenesis. (E) Dynamic
epigenome correlates well with the dynamic transcriptome during adipogenesis. Shown are heat maps of average gene expression levels determined by
RNA-Seq, H3K4me1/2 and H3K27ac levels on enhancers, H3K4me3 levels on promoters, H3K36me3 levels over gene bodies and overall (gene body,
promoter and distal region) H3K27me3 levels for the five groups of genes during adipogenesis.

Pparg, Cebpa and Fabp4 as SE-associated genes but only
MLL4 was able to identify the brown marker gene Ucp1 in
D7 adipocytes. SEs identified by three methods on Pparg
and Cebpa loci are shown in Figure 6C. GO analysis of
genes associated with SEs revealed similar results from three
methods and identified brown fat cell differentiation and
fat cell differentiation as significant GO terms (Supplementary Figure S4). Thus, MLL4 and CBP can identify SEs in
adipocytes.
Further analysis revealed higher levels of MLL4 and CBP
at individual SECs than at TEs (Figure 6D and Supplementary Figure S5). D7 SECs and TEs both have very low levels

of MLL4 and CBP before adipogenesis (D-3 and D0), indicating that SECs gain more MLL4 and CBP than TEs do
during differentiation. Comparison of MLL4 signal intensities at MLL4-defined D0, D2 and D7 SEs revealed that
MLL4 signal intensities increase from D0 to D7 (Figure
6E). Interestingly, 374 D7 SECs, which belong to 49% of
SEs (215/438), are marked by MLL4 at D0 (Supplementary
Figure S6A). These SECs show open chromatin features at
D0, with high levels of H3K4me1, H3K27ac and FAIRE
signals (Supplementary Figure S6B). For example, SEs on
Pparg, Cebpa and Ucp1 loci are bound by MLL4 at their
constituents at D0 (Supplementary Figure S6C). Further-
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Figure 4. MLL4 and CBP drive the dynamic enhancer epigenome in adipogenesis. Only MLL4 and CBP binding sites within enhancers are included. (A)
Genomic distribution of MLL4 and CBP binding in adipogenesis. (B and C) Relationship between changes in MLL4 (B) or CBP (C) binding intensity and
their respective histone modification levels. MLL4 and CBP sites were classified into three groups according to their changes in binding intensity between
neighboring time points: decreased, unchanged and increased (see Supplementary Figure S2A for details). (D and E) MLL4 and CBP drive the dynamics
of their respective histone modifications on enhancers. Only MLL4/CBP binding sites corresponding to the most enriched temporal pattern for each group
were included when generating the heat maps. The enrichment of temporal MLL4/CBP binding patterns is shown in Supplementary Figure S2B. (D) Heat
maps of MLL4 and H3K4me1 on enhancer MLL4 binding sites. (E) Heat maps of CBP and H3K27ac on enhancer CBP binding sites.

more, ∼60 and 30% of MLL4-bound SECs at D0 are bound
by EBF2 and C/EBP␤, respectively (Figure 6F). These results indicate that MLL4, EBF2 and C/EBP␤ pre-mark a
subset of SECs prior to adipogenesis.
We then asked whether MLL3/MLL4 are required
for the formation of SEs. Deletion of Mll4 from Mll3
KO preadipocytes severely decreased CBP, MED1 and
H3K27ac levels at D2 SEs identified by MLL4, including
the ones on Pparg and Cebpa loci (Figure 6G and Sup-

plementary Figure S7). Together, these results demonstrate
that MLL4 and CBP are able to identify SEs and that
MLL3/MLL4 are required for the formation of SEs in adipogenesis.
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Figure 5. MLL3/MLL4 are required for CBP/p300 binding on enhancers activated in adipogenesis. Mll3−/− Mll4f/f brown preadipocytes were infected
with adenoviral GFP or Cre as described (5). Cells were collected at D2 of adipogenesis for ChIP-Seq of CBP and p300. Cells were collected at D0 and
D2 of adipogenesis for western blot analysis of MLL4, CBP and p300. (A–C) MLL3/MLL4 facilitate CBP/p300 binding on active enhancers at D2. (A)
Aggregated profiles. (B) Heat maps. (C) Deletion of Mll4 causes more severe impairment of CBP/p300 binding at MLL4+ than at MLL4− CBP/p300 sites
on active enhancers. (D) Western blot analysis of MLL4, CBP and p300 at D0 and D2. RbBP5 serves as the loading control. (E) Genome browser view of
enhancers (highlighted in gray) around the Pparg locus, where the deletion of Mll3/Mll4 resulted in decreases of CBP and p300 binding at D2. (F) MLL4
physically interacts with UTX and RbBP5 but not CBP/p300 during adipogenesis. Nuclear extracts of cells collected at D2 of adipogenesis were incubated
with MLL4, CBP or p300 antibody. Immunoprecipitates were analyzed by western blot using antibodies indicated on the right.
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Figure 6. MLL4 identifies and is required for super-enhancer (SE) formation in adipogenesis. (A–C) MLL4 and CBP identify SEs in D7 brown adipocytes.
(A) D7 SEs identified using MLL4, CBP or TFs + MED1 (29). (B) Venn diagram showing the overlaps between three groups of SEs identified in (A).
Representative genes associated with MLL4-specific and common SEs are indicated. (C) SEs on Pparg and Cebpa loci. SE regions identified by each
approach are indicated by color bars. (D) MLL4 and CBP are preferentially enriched on SE constituents (SECs). MLL4 and CBP signal levels are shown
for SECs and typical enhancers (TEs) from D-3 to D7. SEs were identified using MLL4 in D7 brown adipocytes. See Supplementary Figure S5 for results
on SEs identified using CBP or TFs + MED1. (E) MLL4 signal intensities on SEs increase from D0 to D7. SEs are defined by MLL4 at each time point.
(F) D7 SECs pre-marked by MLL4 at D0 are enriched with the binding of EBF2 and C/EBP␤ but not C/EBP␣ and PPAR␥ . (G) Deletion of Mll4 from
Mll3 KO preadipocytes severely decreases CBP, MED1 and H3K27ac levels at SEs identified by MLL4 in D2 cells. D2 SEs were identified by MLL4 as
shown in Supplementary Figure S7. The signal levels on SEs of Pparg (red star) and Cebpa (blue triangle) are indicated.

6398 Nucleic Acids Research, 2017, Vol. 45, No. 11

MLL4 identifies primed super-enhancers of BAT-selective
genes Ucp1, Cidea and Gpd2 in brown adipocytes differentiated in culture
In addition to common SEs identified by all three methods, 155 SEs were identified by MLL4 only (Figure 6B).
These MLL4-specific SEs show lower levels of H3K4me1,
H3K27ac and associated gene expression than common
SEs do (Figure 7A). GO analysis indicated that while both
MLL4-specific and common SE-associated genes are linked
to brown fat cell differentiation, only MLL4-specific SEassociated genes are linked to temperature homeostasis, a
major function of BAT (Figure 7B). RNA-Seq analyses revealed 10 genes that are expressed at much higher levels (>5fold) in BAT than in D7 brown adipocytes (Figure 7C and
Supplementary Figure S8A). They include BAT-selective
genes Ucp1, Cidea and Gpd2 as well as Adrb1 (beta 1 adrenergic receptor) (19), all of which are critical for the thermogenesis function of BAT. While Ucp1, Cidea and Gpd2 are
markedly induced from preadipocytes (D0) to adipocytes
(D7), their absolute levels in D7 brown adipocytes are much
lower than in BAT. In contrast, the general adipogenesis gene Pparg is expressed at similar levels (Figure 7D).
These results suggest that SEs of these BAT-selective genes
are primed but not fully activated in D7 brown adipocytes
differentiated in culture. Indeed, by comparing ChIP-Seq
data from D7 brown adipocytes with those from BAT (34),
we found that H3K27ac levels at MLL4-identified SEs on
Ucp1, Cidea and Gpd2 loci were much lower in D7 brown
adipocytes than in BAT, whereas H3K4me1 levels were
comparable. In contrast, both H3K4me1 and H3K27ac levels at MLL4-identified SEs on the Pparg locus were comparable in D7 brown adipocytes and in BAT (Supplementary Figure S8B and C; Figure 7E). Thus, MLL4 identifies primed SEs of several BAT-selective genes in brown
adipocytes differentiated in culture.
Comparative epigenomic analysis of brown and white adipogenesis
Next we compared our datasets with published ChIP-Seq
(35) and RNA-Seq (12) datasets on 3T3-L1 white adipogenesis. For this purpose, we also generated MLL4 ChIP-Seq
dataset at D7 of 3T3L1 adipogenesis. As shown in Figure
8 and Supplementary Figure S9, PPAR␥ and MLL4 bind
Ucp1 and Prdm16 loci at D7 of brown but not white adipogenesis. In contrast, they bind the Pparg locus in both
brown and white adipocytes. Signal levels of active histone
marks H3K4me1/2/3, H3K27ac and H3K36me3 on the
Prdm16 locus increase in brown but not white adipogenesis. In contrast, their levels on the Pparg locus increase in
both brown and white adipogenesis (Figure 8). Levels of the
repressive histone modification H3K27me3 on Ucp1 and
Prdm16 loci are generally lower at both D0 and D7 in brown
than in white adipogenesis. Consistent with the ChIP-Seq
results, RNA-Seq data showed that Ucp1 and Prdm16 are
only induced in brown adipogenesis while Pparg is induced
in both brown and white adipogenesis.
Further, we compared MLL4-defined SEs at D7 of brown
and white adipogenesis. Combined with RNA-Seq data
from both brown and white adipogenesis, we identified 153
common and 285 brown-specific SEs (Figure 9A). The 153

common SEs associated with 149 genes including general
adipogenic genes such as Pparg, Cebpa, Cebpb and Fabp4
(Figure 9B and D). Meanwhile, we identified 177 genes with
higher expression in brown than in white adipocytes at D7.
Among them, 28 were brown-specific SE-associated genes
(Figure 9A and B; Supplementary Table S4). In addition
to known brown-enriched genes such as Ucp1, Ebf2, Cidea
and Gpd2 (19,20) (Figure 9B–F), these brown-specific SEassociated genes also included genes such as Aspg, Chchd10,
Id2 and Pim1 (Figure 9B, G–J), whose functions in BAT development and/or function need to be validated in the future.
DISCUSSION
Following established protocols, we immortalized primary
preadipocytes isolated from mouse BAT. By epigenomic
profiling of preadipocyte differentiation at four time points,
we show that enhancer epigenomic writers MLL3/MLL4
and CBP/p300 drive the enhancer epigenome. Importantly,
MLL3/MLL4 are required for CBP/p300 binding on enhancers activated during adipogenesis, thus revealing novel
insights into the mechanism by which MLL3/MLL4 regulate enhancer activation during cell differentiation. We also
report that MLL4 and CBP can identify SEs of adipogenesis and that MLL3/MLL4 are required for the formation
of SEs. Further, in brown adipocytes differentiated in culture, MLL4 identifies primed SEs of Ucp1 and other BATselective genes. Our data also serve as a rich resource for
understanding epigenomic regulation of brown adipogenesis.
Enhancer regulation by MLL3/MLL4 and CBP/p300
MLL3/MLL4 and CBP/p300 are major epigenomic writers for enhancer marks H3K4me1/2 and H3K27ac, respectively. As expected, changes of CBP binding on enhancers
positively correlates with changes of H3K27ac levels. Interestingly, while increases in MLL4 binding on enhancers
lead to increased H3K4me1, decreased MLL4 binding only
leads to a mild decrease in H3K4me1 levels (Figure 4B).
This unexpected result could be due to the compensation
for the loss of MLL4 on enhancers by other H3K4 methyltransferases and/or the failure of H3K4 demethylases to
remove H3K4me1 on enhancers. MLL3/MLL4-mediated
H3K4me1 on enhancers may serve the memory function
to keep the primed enhancers open and accessible and facilitate rapid activation/re-activation by subsequent stimuli (1). Another interesting finding is that the fractions of
MLL4/CBP on promoter regions increase during adipogenesis (Figure 4A), which could be due to the increased
enhancer-promoter interactions that bring enhancer-bound
MLL4/CBP to promoter regions.
We showed previously that MLL3/MLL4 are required
for H3K27ac on enhancers activated during adipogenesis
(5), but the mechanism was unclear. Here we show that
MLL3/MLL4 regulate enhancer activation by facilitating
enhancer-binding of H3K27 acetyltransferases CBP/p300.
It remains to be determined how MLL3/MLL4 facilitate
CBP/p300 binding on enhancers. MLL4 complex does
not physically interact with CBP/p300 during adipogenesis
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Figure 7. MLL4 identifies primed SEs of BAT-selective genes Ucp1, Cidea and Gpd2 in brown adipocytes differentiated in culture. (A) MLL4-specific SEs
show lower levels of H3K4me1, H3K27ac and expression levels of SE-associated genes than common SEs do. Significance was determined using Mann–
Whitney test. (B) GO analysis of MLL4-specific and common SE-associated genes. (C) Comparison of MLL4-specific SE-associated gene expression in
D7 brown adipocytes and in BAT. Data were obtained by RNA-Seq. (D) Expression levels of BAT-selective genes (Ucp1, Cidea and Gpd2) and Pparg in
preadipocytes (D0) and adipocytes (D7) during brown adipogenesis and in BAT. (E) Genome browser views of MLL4 binding, H3K4me1 and H3K27ac
levels, and RNA-Seq at Ucp1, Cidea, Gpd2 and Pparg loci. Red bars underneath the genome browser tracks indicate MLL4-defined SE regions.
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Figure 8. Comparative epigenomic profiling of brown and white adipogenesis on Prdm16 and Pparg loci. ChIP-Seq and RNA-Seq data on Prdm16 (A)
and Pparg (B) loci before (D0) and after (D7) adipogenesis of brown preadipocytes (left) and 3T3L1 white preadipocytes (right) are shown.
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Figure 9. Identification of brown-specific SE-associated genes. (A) Flowchart of identifying common and brown-specific SE-associated genes. (B) Examples
of common and brown-specific SE-associated genes. See Supplementary Table S4 for the full list. (C–J) Genome browser views of MLL4 ChIP-Seq and
RNA-Seq data at D7 of adipogenesis of 3T3L1 and brown preadipocytes on selected SE-associated genes. Red bars underneath the genome browser
tracks indicate MLL4-defined SE regions in brown adipocytes. (C–D) Common SE-associated genes Pparg and Cebpa are shown. (E–J) Brown-specific
SE-associated genes Ucp1, Ebf2, Aspg, Chchd10, Id2 and Pim1 are shown.
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(Figure 5F). One possibility is that MLL3/MLL4 facilitate
the chromatin opening on enhancers, which in turn facilitates CBP/p300 binding.

showed that deletion of Id2 leads to impaired thermogenesis and a reduction in core body temperature in mice (40),
suggesting that Id2 is involved in BAT function.

MLL4 and CBP identify SEs

ACCESSION NUMBER

SEs are enriched with exceptionally high levels of transcription coactivators including Mediator (represented by the
MED1 subunit), and are linked to key cell identity genes
(29). SEs can be identified by using TFs + MED1, H3K27ac
or BRD4, all of which are enriched at enhancers (29,36,37).
As expected, the H3K27 acetyltransferase p300 can also
identify SEs (38). In this study, we show that both CBP,
which is the ortholog of p300 and MLL4, which is enriched
on active and primed enhancers during adipogenesis, can
identify SEs. Interestingly, MLL4 identifies primed SEs of
genes critical for the thermogenesis function of BAT, such
as Ucp1 and Adrb1, in brown adipocytes differentiated in
culture. These primed SEs show similar levels of H3K4me1
but much lower levels of H3K27ac and expression of SEassociated genes in brown adipocytes than in the BAT. The
primed state of these SEs in brown adipocytes differentiated
in culture suggests that additional signaling pathways and
their down-stream TFs are critical for the full activation of
these SEs in BAT in vivo. Future work on epigenomic profiling of brown adipocytes in vivo would help identify signaling
pathways and down-stream TFs critical for BAT functions.

All datasets described in the paper have been deposited
in NCBI Gene Expression Omnibus under access #
GSE74189.

Epigenomic profiling of brown adipogenesis
A previous study reported the epigenomic profiling of
white adipogenesis using immortalized murine 3T3-L1
cells and primary human adipose stromal cells (35). We
report the epigenomic profiling of adipogenesis using
immortalized murine brown preadipocytes. In addition
to ChIP-Seq of H3K4me1/2/3, H3K27me3, H3K36me3,
H3K27ac, PPAR␥ and CTCF, which were reported in
(35), we performed ChIP-Seq of H3K9me2, adipogenic TFs
EBF2, C/EBP␤ and C/EBP␣, enhancer epigenomic writers MLL4 and CBP, MED1, Pol II, FAIRE-Seq of chromatin opening and RNA-Seq of transcriptome. Our study
provides a more comprehensive resource for understanding
epigenomic regulation of adipogenesis. We show that enhancer epigenomic writers, H3K4me1/2 methyltransferases
MLL3/MLL4 and H3K27 acetyltransferases CBP/p300,
drive the dynamic enhancer epigenome during adipogenesis. Further, we confirm the finding by Mikkelsen et al.
that dynamic changes in enhancer H3K27ac correlate with
changes in gene expression levels. We show that dynamic
enhancer H3K4me1/2 also correlate with dynamic transcriptome, thus establishing the strong correlation between
dynamic enhancer epigenome and dynamic transcriptome
during adipogenesis.
By comparing MLL4-defined SEs and transcriptome in
brown and white adipogenesis, we obtained a list of brownspecific SE-associated genes. These genes include known
and predicted genes that regulate BAT development or
function. Interestingly, two very recent papers independently validated the potential roles of Id2 and Pim1 in BAT
development/function. One showed that Pim1 promotes
brown adipogenesis of C3H10T1/2 cells (39). The other
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